-
Product Insights
Dermatomyositis – Drugs In Development, 2023
Global Markets Direct’s, ‘Dermatomyositis - Drugs In Development, 2023’, provides an overview of the Dermatomyositis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Dermatomyositis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Idiopathic Inflammatory Myopathy (IIM) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Idiopathic Inflammatory Myopathy (IIM) Clinical Trial Report Overview The total number of idiopathic inflammatory myopathy (IIM) clinical trials conducted as of December 2023 was 252. The IIM clinical trial report includes information about the sponsor type and the prominent sponsors associated with the IIM clinical trials. The report provides a comprehensive understanding of the IIM clinical trial scenario across regions, and countries (G7 & E7), covering details on the various phases, trial status, and end points status. The IIM clinical...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.